IBM PAS successfully passes EU-OPENSCREEN ERIC Partner Site re-evaluation

We are proud to announce that the Institute of Medical Biology of the Polish Academy of Sciences (IBM PAS) has received a positive assessment in the 2025 re-evaluation as a Partner Site of the EU-OPENSCREEN ERIC research infrastructure. International reviewers praised our scientific excellence, technical capabilities, and strategic vision for 2027–2029.

The evaluation report highlights our unique expertise in screening for anti-viral and anti-bacterial compounds, supported by BSL-2 and BSL-3 facilities. A major recognized strength is the National Library of Chemical Compounds (NLCC) hosted at IBM PAS, which provides the scientific community with access to unique chemical diversity. This successful re-evaluation confirms our position as a key specialized site for early drug discovery within the European research landscape.